Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 289

1.
3.

Nonsteroidal anti-inflammatory drugs: how do they damage gastroduodenal mucosa?

Scarpignato C.

Dig Dis. 1995 Jan;13 Suppl 1:9-39. Review.

PMID:
7697906
4.

Anti-inflammatory drugs in the 21st century.

Rainsford KD.

Subcell Biochem. 2007;42:3-27. Review.

PMID:
17612044
5.
6.

Pathogenesis of NSAID-induced gastroduodenal mucosal injury.

Wallace JL.

Best Pract Res Clin Gastroenterol. 2001 Oct;15(5):691-703. Review.

PMID:
11566035
8.

COX inhibition and NSAID-induced gastric damage--roles in various pathogenic events.

Takeuchi K, Tanaka A, Hayashi Y, Yokota A.

Curr Top Med Chem. 2005;5(5):475-86. Review.

PMID:
15974942
9.

Gastrointestinal effects of nonsteroidal anti-inflammatory drugs.

Whittle BJ.

Fundam Clin Pharmacol. 2003 Jun;17(3):301-13. Review.

PMID:
12803569
10.

Gastro-intestinal lesions induced by non-steroidal anti-inflammatory drugs.

Albu R, Dragomir P, Voiosu R.

Rom J Intern Med. 1998 Jul-Dec;36(3-4):145-59. Review.

PMID:
10822511
11.

Intestinal mucosal damage caused by non-steroidal anti-inflammatory drugs: role of bile salts.

Petruzzelli M, Vacca M, Moschetta A, Cinzia Sasso R, Palasciano G, van Erpecum KJ, Portincasa P.

Clin Biochem. 2007 May;40(8):503-10. Epub 2007 Jan 31. Review.

PMID:
17321514
12.

Mechanisms of gastrointestinal toxicity of non-steroidal anti-inflammatory drugs.

Rainsford KD.

Scand J Gastroenterol Suppl. 1989;163:9-16. Review.

PMID:
2683030
13.

Mucosal damage induced by preferential COX-1 and COX-2 inhibitors: role of prostaglandins and inflammatory response.

Villegas I, La Casa C, de la Lastra CA, Motilva V, Herrerías JM, Martín MJ.

Life Sci. 2004 Jan 2;74(7):873-84.

PMID:
14659976
14.

Physiological mediators in nonsteroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation. Focus on nitric oxide and lipoxins.

Brzozowski T, Konturek PC, Pajdo R, Ptak-Belowska A, Kwiecien S, Pawlik M, Drozdowicz D, Sliwowski Z, Brzozowski B, Konturek SJ, Pawlik WW.

J Physiol Pharmacol. 2008 Aug;59 Suppl 2:89-102. Review.

15.

Role of direct cytotoxic effects of NSAIDs in the induction of gastric lesions.

Tomisato W, Tsutsumi S, Hoshino T, Hwang HJ, Mio M, Tsuchiya T, Mizushima T.

Biochem Pharmacol. 2004 Feb 1;67(3):575-85.

PMID:
15037209
16.

Inhibition of both COX-1 and COX-2 and resulting decrease in the level of prostaglandins E2 is responsible for non-steroidal anti-inflammatory drug (NSAID)-dependent exacerbation of colitis.

Tanaka K, Suemasu S, Ishihara T, Tasaka Y, Arai Y, Mizushima T.

Eur J Pharmacol. 2009 Jan 28;603(1-3):120-32. doi: 10.1016/j.ejphar.2008.11.058. Epub 2008 Dec 6.

PMID:
19101538
17.
18.

Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs.

Smecuol E, Bai JC, Sugai E, Vazquez H, Niveloni S, Pedreira S, Mauriño E, Meddings J.

Gut. 2001 Nov;49(5):650-5.

19.

Anti-inflammatory and side effects of cyclooxygenase inhibitors.

Süleyman H, Demircan B, Karagöz Y.

Pharmacol Rep. 2007 May-Jun;59(3):247-58. Review.

20.

[Effect of lysine clonixinate and indomethacin on lipoxygenase and cyclooxygenase activity in colon isolated from cancer patients].

Franchi A, Di Girolamo G, de los Santos AR, Marti ML, Gimeno MA.

Medicina (B Aires). 1998;58(3):291-4. Spanish.

PMID:
9713099
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk